COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,220 Articles (22,733 medRxiv, 8,487 bioRxiv)

Most recent first Previous |  Page 728: Articles 7271-7280  | Next

U.S. state-level COVID-19 transmission insights from a mechanistic mobility-incidence model
Thommes, E. W., Mohammadi, Z., Flynn-Primrose, D., Smook, S., Gomez, G., Chaves, S. S., Coudeville, L., van Aalst, R., Mahe, C., Cojocaru, M. G.
10.1101/2022.06.21.22276712 — Posted: 2022-06-22
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Farjo, M., Koelle, K., Martin, M. A., Gibson, L. L., Walden, K. K., Rendon, G., Fields, C. J., Alnaji, F., Gallagher, N., Luo, C. H., Mostafa, H. H., Manabe, Y. C., Pekosz, A., Smith, R. L., McManus, D. D., Brooke, C. B.
10.1101/2022.06.21.497047 — Posted: 2022-06-22
Mutational insights among the structural proteins of SARS-CoV-2: frequencies and evolutionary trends in American countries
Abavisani, M., Rahimian, K., Khayami, R., Mollapour Sisakht, M., Mahmanzar, M., Meshkat, Z.
10.1101/2022.06.22.497134 — Posted: 2022-06-22
Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.
Takeshita, M., Fukuyama, H., Kamada, K., Matsumoto, T., Makino-Okamura, C., Uchikubo-Kamo, T., Tomabechi, Y., Hanada, K., Moriyama, S., Takahashi, Y., Ishigaki, H., Nakayama, M., Nguyen, C. T., Kitagawa, Y., Itoh, Y., Imai, M., Maemura, T., Furusawa, Y., Ueki, H., Iwatsuki-Horimoto, K., Ito, M., Yamayoshi, S., Kawaoka, Y., Shirouzu, M., Ishii, M., Saya, H., Kondo, Y., Kaneko, Y., Suzuki, K., Fukunaga, K., Takeuchi, T.
10.1101/2022.06.21.496751 — Posted: 2022-06-22
Increased levels of circulating neurotoxic metabolites in patients with mild Covid19
Santiago-Mujika, E., Heinrich, K., George, S., Capan, C. D., Forton, C., Madaj, Z., Burmeister, A. R., Sims, M., Pospisilik, A., Brundin, P., Graham, S. F., Brundin, L.
10.1101/2022.06.22.497189 — Posted: 2022-06-22
Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C
Loy, C. J., Sotomayor-Gonzalez, A., Servellita, V., Nguyen, J., Lenz, J., Bhattacharya, S., Williams, M. E., Cheng, A. P., Bliss, A., Saldhi, P., Brazer, N., Streithorst, J., Suslovic, W., Hsieh, C., Bahar, B., Wood, N., Foresythe, A., Gliwa, A., Bhakta, K., Perez, M. A., Hussaini, L., Anderson, E. J., Chahroudi, A., Delaney, M., Butte, A. J., DeBiasi, R., Rostad, C. A., De Vlaminck, I., Chiu, C. Y.
10.1101/2022.06.21.22276250 — Posted: 2022-06-22
Leveraging serology testing to identify children at risk for post-acute sequelae of SARS-CoV-2 infection: An EHR-based cohort study from the RECOVER program
Mejias, A., Schuchard, J., Rao, S., Bennett, T. D., Jhaveri, R., Thacker, D., Bailey, C. C., Christakis, D., Pajor, N., Razzaghi, H., Forrest, C. B., Lee, G. M.
10.1101/2022.06.20.22276645 — Posted: 2022-06-22
VirPool: Model-Based Estimation of SARS-CoV-2 Variant Proportions in Wastewater Samples
Gafurov, A., Balaz, A., Amman, F., Borsova, K., Cabanova, V., Klempa, B., Bergthaler, A., Vinar, T., Brejova, B.
10.1101/2022.06.21.22276717 — Posted: 2022-06-22
Effectiveness of Subcutaneous Casirivimab and Imdevimab Relative to no COVID-19 Antibody Treatment Among Patients Diagnosed With COVID-19 in the Ambulatory Setting
Jalbert, J. J., Hussein, M., Mastey, V., Sanchez, R. J., Wang, D., Murdock, D., Farinas, L., Bussey, J., Duart, C., Hirshberg, B., Weinreich, D. M., Wei, W.
10.1101/2022.06.20.22276636 — Posted: 2022-06-22
Effects of the COVID-19 pandemic on self-reported 12-month pneumococcal vaccination series completion rates in Canada: An interrupted time-series analysis
Atkinson, K. M., Ntacyabukura, B., Hawken, S., Laflamme, L., Wilson, K.
10.1101/2022.06.21.22276720 — Posted: 2022-06-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).